News

Medidata Solutions has extended its multi-year contract with Shire for use of Medidata Grants Manager and CRO Contractor benchmarking and analysis tools for investigator site and contract research

The company claims that the SQiDworks Diagnostics Platform and its IgXPLEX RA assay provide clinical laboratories with the ability to simultaneously measure multiple biomarkers in a single test

Mayo Clinic Proceedings has published data from a pivotal phase III trial, which demonstrated that Nuvigil (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with

Dow Chemical Company has moved Geoffery Merszei, executive vice president and chief financial officer, to a new role as president of Dow Europe, Middle East and Africa. He

Novartis reported that it will invest $1billion over the next five years, increasing R&D activities in China. The company’s investment will include a significant expansion of The Novartis

Trevena has been awarded a $7.65m Grand Opportunity (GO) Grant by the office of the director of the National Institutes of Health (NIH). The grant will further fund

Valeant Pharmaceuticals (Valeant) has provided additional results from the week-72 analysis of its phase IIb dose-finding clinical trial for taribavirin, a prodrug of ribavirin which is in development

The US Patent and Trademark Office (USPTO) has issued US Patent No 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin” to Salix Pharmaceuticals

Calmune has established an exclusive research collaboration with Crucell, which focuses on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases.